R&D Partner Content Welcome to the 3rd Spatial Biology for Drug Development Summ... Transforming Research & Development with Faster, More Precise Spatial Insights
R&D Partner Content Unlocking the Potential of Targeting the Innate Immune Syste... Ready to Catalyze the Next Wave of Inflammasome Therapies?
R&D Supercharging clinical development with RWE – with Recursion... Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
